Structure-activity relationships of indole cytosolic phospholipase A 2α inhibitors: Substrate mimetics

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 24, 2003, Pages 4501-4504

  McKew, John C ^a   Lovering, Frank ^a   Clark, James D ^b   Bemis, Jean ^a   Xiang, YiBin ^a   Shen, Marina ^b   Zhang, Wen ^b   Alvarez, Juan C ^a   Joseph McCarthy, Diane ^a  

^a PFIZER INC   (United States)

^b The Inflammation Research Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPASE A2 INHIBITOR;

CONFERENCE PAPER; ENZYME ASSAY; ENZYME ISOLATION; MOLECULAR MODEL; STRUCTURE ACTIVITY RELATION;

EID: 0344064798     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2003.08.070     Document Type: Conference Paper

References (17)

1. (a) Clark J.D., Schievella A.R., Nalefski E.A., Lin L.-L. J. Lipid Mediators Cell Signal. 12:1995;83 (b) Six D.A., Dennis E.A. BioChim. BioPhys. Acta. 1488:2000;1.
2. Smith W.L. Biochem. J. 259:1989;315.
3. Wasserman S.I. Hosp. Pract. 15:1988;49.
4. (a) Sapirstein A., Bonventre J.V. Biochim. Biophys. Acta. 1488:2000;139 (b) Nagase T., Uozumi N., Ishii S., Kume K., Izumi T., Ouchi Y., Shimizu T. Nat. Immunol. 1:2000;42 (c) Lehr M. Drugs Future. 25:2000;823.
5. Dessen A., Tang J., Schmidt H., Stahl M., Clark J.D., Seehra J., Somers W. Cell. 97:1999;349.
6. Lehr M. J. Med. Chem. 40:1997;2694.
7. Abdullah K.H., Perrier H., Leger S. Bioorg. Med. Chem. Lett. 5:1995;519.
8. Matassa V.G., Maduskuie T.P., Shapiro H.S., Heep B., Snyder D.W., Aharony D., Krell R.D., Keith R.A. J. Med. Chem. 33:1990;1781.
9. Gilliard J.W., Ford-Hutchinson A.W., Chan C., Charleson S., Denis D., Foster A., Fortin R., Legere S., McFarlane C.S., Morton H., Piechuta H., Riendeau D., Rouzer C.A., Rokach J., Young R.N., MacIntyre D.E., Peterson L., Bach T., Eiermann G., Hopple S., Humes J., Hupe D., Luell S., Metzger J., Meurer R., Miller D.K., Opas E., Pachalok S. Can. J. Physiol. Pharmacol. 67:1989;456.
10. (a) . For a more rigorous approach to arachidonic acid mimetics, see: Bonzom P.M., Toth G., Gibbons W.A. Biochemical Society Transactions. 26: 1998;S32 (b) Bonzom P.M., Zloh M., Reid R.E., Gibbons W.A. Biochem. Soc. Trans. 25:1997;26. S.
11. Biological data are the mean of multiple experiments performed in duplicate: Huang Z., Laliberte F., Tremblay N.M., Weech P.K., Street I.P. Anal. Biochem. 222:1994;110.
12. Hagmann W. Biochem. J. 299(Pt 2):1994;467.
13. (a) Mahadevan A., Sard H., Gonzalez M., McKew J.C. Tetrahedron Lett. 44:2003;4589 (b) Appleton J.E., Dack K.N., Green A.D., Steele J. Tetrahedron Lett. 34:1993;1529.
14. 1H NMR and either HRMS, LC/MS or CHN.
15. Formulation for PO PK studies was EtOH/PEG 400. Analysis was performed with HPLC (UV detection).
16. McMartin C., Bohacek R.S. J. Comput.-Aided Mol. Des. 11:1997;333.
17. The figure was generated using InsightII (Accelyrs, 2002, San Diego, CA, USA).